一个BRN2:MYC转录轴调节了黑色素瘤中耐疗和瘤原生表型之间的相互转换
Yuntian Zhang1, Marcus A Urquijo2, Rebecca G Zitnay3
1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA.
Cell reports
|December 17, 2025
概括
黑色素瘤细胞在转录状态之间呈现加速切换,与黑色素细胞不同. 这种由MYC和BRN2驱动的快速表型切换是黑色素瘤进展和治疗耐药性的关键.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 转移性传播和治疗耐药性是癌症死亡率的主要驱动因素.
- 黑色素瘤的进展涉及不同的细胞转录状态之间的过渡.
- 了解黑色素瘤细胞状态切换机制对于开发有效疗法至关重要.
研究的目的:
- 研究黑色素瘤细胞中转录状态切换的机制.
- 为了比较黑色素瘤细胞状态切换与黑色素细胞的状态切换.
- 识别不同的黑色素瘤细胞表型及其在瘤启动和抵抗中的作用.
主要方法:
- 隔离和特征不同的黑色素瘤细胞状态.
- 黑色素瘤和黑色素细胞状态的表型和转录分析.
- 细胞状态之间的过渡频率的分析.
主要成果:
- 确定了一种MYC驱动的状态,对瘤启动至关重要,对BRAF抑制敏感.
- 鉴定了一种与治疗耐药性相关的不分化,高BRN2状态.
- 发现BRN2高状态存在于黑色素瘤和黑色素细胞中,而MYC状态仅限于黑色素瘤.
- 与黑色素细胞相比,在黑色素瘤细胞中观察到状态过渡的频率增加.
结论:
- 加快的表型转换,而不仅仅是状态多样性,定义了黑色素瘤的进展.
- 针对快速状态过渡可能为黑色素瘤提供新的治疗策略.
- 特定的转录状态,如MYC驱动和BRN2高,在黑色素瘤的攻击性行为中起着关键作用.
相关概念视频
Induced Pluripotent Stem Cells
5.3K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Master Transcription Regulators
7.6K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K


